Theragenics (FRA:THX) Total Stockholders Equity : €58.76 Mil (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Theragenics Total Stockholders Equity?

Theragenics's Total Stockholders Equity for the quarter that ended in Jun. 2013 was €58.76 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Theragenics's Book Value per Share for the quarter that ended in Jun. 2013 was €2.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Theragenics's Debt-to-Equity for the quarter that ended in Jun. 2013 was 0.28.

Theragenics Total Stockholders Equity Historical Data

The historical data trend for Theragenics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragenics Total Stockholders Equity Chart

Theragenics Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Total Stockholders Equity

Get a 7-Day Free Trial

54.84

53.27

60.69

63.93

58.62

Theragenics Quarterly Data
	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13
Total Stockholders Equity	Get a 7-Day Free Trial															68.87	59.76	58.62	59.59	58.76

Theragenics (FRA:THX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Theragenics's Book Value per Share for the quarter that ended in Jun. 2013 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(58.764	-	0)	/	29.277
	=	2.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Theragenics's Debt-to-Equity for the quarter that ended in Jun. 2013 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	16.676)	/	58.764
	=	0.28

Theragenics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Theragenics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Theragenics (FRA:THX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theragenics Corporation (FRA:THX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.theragenics.com

Theragenics Corporation is a Delaware Corporation formed in 1981. It is a medical device company serving the surgical products and cancer treatment markets, operate in two business segments; the surgical products segment and the brachytherapy seed segment. The Company's surgical products business manufactures markets and sells disposable devices utilized in certain surgical procedures. Its brachytherapy seed business manufactures markets and sells radioactive 'seeds' utilized in the treatment of early stage prostate cancer. Its surgical products business was built through the acquisitions of CP Medical Corp. in May 2005, Galt Medical Corporation in August 2006, and NeedleTech Products, Inc. in July 2008. The Company manufactures almost 3,500 products in this business as part of three broad product platforms; wound closure, vascular access and specialty needles. It serves a number of markets and applications, including, among other areas, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. With the exception of veterinary sutures, its surgical products hold relatively small market shares. Its products include both finished goods and components. The Company's products are sold mainly to original equipment manufacturers and to a network of distributors. The Company's facilities and operations are subject to extensive environmental, nuclear, regulatory and occupational health and safety laws at the federal, state and local levels. It is also subject to similar foreign laws and regulations under certain circumstances when its products are distributed outside of the United States.

Theragenics (FRA:THX) Headlines

No Headlines